Lyell Immunopharma, Inc. H-1B wage filings
South San Francisco, CA. Last filed in fiscal 2026. Figures cover every filing since fiscal 2020; none in the latest 12 months reach five.
Lyell Immunopharma, Inc. filed 20 wage applications for H-1B and similar visas from fiscal 2020 to fiscal 2026. The median wage it offered was $165,000, 13.6% above the government's prevailing wage for the same jobs. Its most-filed job was Senior Business Analyst, Financial Systems (5 filings, median $165,000).
- Filings since FY2020
- 20
- Positions covered
- 19
- Certified
- 95.0%
- Job titles
- 11
- Worksite cities
- 3
- Last filed
- FY2026
Offered wage since 2020
Lyell Immunopharma, Inc. made 20 filings across 7 fiscal years since 2020, too few in most years to track the wage year by year. Its busiest full year was fiscal 2022, with 5 filings.
Middle half of offered wagesMedian offered wageMedian prevailing wageFilings per year
Fiscal years run October to September. Fiscal 2026 is still running: these figures cover October 2025 to June 2026.
Lyell Immunopharma, Inc. by fiscal year
| Fiscal year | Filings | Median offered | vs year before | Median prevailing | vs prevailing |
|---|---|---|---|---|---|
| 2026 (Oct to Jun) | 1 | n/a | n/a | n/a | n/a |
| 2025 | 2 | n/a | n/a | n/a | n/a |
| 2024 | 2 | n/a | n/a | n/a | n/a |
| 2023 | 3 | $195,500 | +22.2% | $195,416 | +8.0% |
| 2022 | 5 | $160,000 | −40.1% | $121,472 | +13.6% |
| 2021 | 4 | $267,094 | +61.9% | $204,277 | +30.8% |
| 2020 | 3 | $165,000 | n/a | $114,962 | +43.5% |
Offered wage by job title
Middle half of offered wagesMedian offered wageMedian prevailing wage
| Job title | Filings | Median offered | Offered range and prevailing wage | vs prevailing |
|---|---|---|---|---|
| Senior Business Analyst, Financial Systems | 5 | $165,000 | +22.0% | |
| Sr. Director of Total Rewards | 3 | $267,094 | +30.8% | |
| Sr. Director, Total Rewards | 2 | $236,639 | +21.1% | |
| Senior Scientist, Translational Pathology Laboratory | 2 | $154,500 | +6.1% | |
| Associate Director, Regulatory | 1 | $197,600 | +13.6% | |
| Clinical Data Platform Product Manager | 1 | $200,000 | +11.0% | |
| Manager of Regulatory | 1 | $133,000 | +25.8% | |
| Manager, SEC Reporting | 1 | $160,000 | +31.7% | |
| Research Associate II, TME & TCE | 1 | $98,325 | +12.2% | |
| Scientist II | 1 | $160,169 | at the minimum | |
| Senior Director, Medical Affairs, Solid Tumors | 1 | $291,304 | at the minimum | |
No job title on this page matches. Only the most-filed titles are listed.
Where the jobs are
| Worksite | Filings | Median offered |
|---|---|---|
| South San Francisco, CA | 15 | $165,921 |
| Seattle, WA | 4 | $165,000 |
| Redwood City, CA | 1 | $291,304 |
By visa type: 17 H-1B, 3 E-3 (Australia). By outcome: 11 certified, 8 certified and later withdrawn, 1 withdrawn before a decision.
Seniority of the jobs filed
The government assigns each job one of four wage levels. A higher level means a higher legal minimum.
What these numbers are
- They are wages Lyell Immunopharma, Inc. attested to on Labor Condition Applications (Form ETA-9035), not paychecks. Bonuses and stock are not included.
- A filing is not a visa or a hire. One filing can cover several positions, and some are later withdrawn. Wage figures use certified filings only.
- The prevailing wage is the minimum the employer must pay for that job in that area, set from government wage surveys.
Source: U.S. Department of Labor, OFLC disclosure data. How we clean and count it.